Chronic migraine becomes “refractory” when preventive treatments don’t work to reduce the frequency of episodes. Treatment may include complementary therapies like neuromodulation.
The PROGRESS trial, which enrolled people with chronic migraine, had 256 on the drug and 246 on placebo. People with episodic migraine experience up to 14 migraine days per month. People with ...
Migraine surgery is rarely recommended as a therapy for migraine. Not enough evidence exists to determine who should get it, if it’s effective, and the long-term risks. Speak with your doctor ...
The 12-week study assessed safety and effectiveness in people with episodic and chronic migraines. In terms of migraine days, participants taking atogepant in the first two trials experienced an ...